Sumitomo Mitsui Trust Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.4M | Buy |
4,729,444
+462,573
| +11% | +$7.87M | 0.05% | 343 |
|
|
2025
Q1 | $83.3M | Buy |
4,266,871
+309,260
| +8% | +$6.04M | 0.06% | 318 |
|
|
2024
Q4 | $98.1M | Buy |
3,957,611
+404,782
| +11% | +$10M | 0.07% | 283 |
|
|
2024
Q3 | $87M | Buy |
3,552,829
+1,328,414
| +60% | +$32.5M | 0.06% | 316 |
|
|
2024
Q2 | $52.1M | Sell |
2,224,415
-137,402
| -6% | -$3.22M | 0.04% | 411 |
|
|
2024
Q1 | $78M | Buy |
2,361,817
+3,726
| +0.2% | +$123K | 0.05% | 370 |
|
|
2023
Q4 | $64.2M | Buy |
2,358,091
+715,911
| +44% | +$19.5M | 0.05% | 403 |
|
|
2023
Q3 | $39.5M | Buy |
1,642,180
+427,100
| +35% | +$10.3M | 0.03% | 526 |
|
|
2023
Q2 | $38.8M | Buy |
1,215,080
+556,514
| +85% | +$17.8M | 0.03% | 544 |
|
|
2023
Q1 | $20.2M | Sell |
658,566
-15,124
| -2% | -$463K | 0.02% | 721 |
|
|
2022
Q4 | $26.3M | Buy |
673,690
+162,759
| +32% | +$6.37M | 0.02% | 658 |
|
|
2022
Q3 | $24.3M | Buy |
510,931
+218,969
| +75% | +$10.4M | 0.02% | 671 |
|
|
2022
Q2 | $11.3M | Buy |
291,962
+8,453
| +3% | +$327K | 0.01% | 792 |
|
|
2022
Q1 | $16.2M | Buy |
283,509
+58,286
| +26% | +$3.34M | 0.01% | 756 |
|
|
2021
Q4 | $17.9M | Sell |
225,223
-29,132
| -11% | -$2.32M | 0.01% | 725 |
|
|
2021
Q3 | $22.1M | Sell |
254,355
-2,210
| -0.9% | -$192K | 0.01% | 700 |
|
|
2021
Q2 | $33M | Buy |
256,565
+27,164
| +12% | +$3.5M | 0.02% | 649 |
|
|
2021
Q1 | $18.4M | Buy |
229,401
+25,159
| +12% | +$2.01M | 0.01% | 724 |
|
|
2020
Q4 | $16.7M | Buy |
+204,242
| New | +$16.7M | 0.01% | 726 |
|